PERIOPERATIVE MYOCARDIAL INFARCTION THE ANAESTHESIOLOGIST'S VIEW

Size: px
Start display at page:

Download "PERIOPERATIVE MYOCARDIAL INFARCTION THE ANAESTHESIOLOGIST'S VIEW"

Transcription

1 PERIOPERATIVE MYOCARDIAL INFARCTION THE ANAESTHESIOLOGIST'S VIEW Bruce Biccard Perioperative Research Group, Department of Anaesthetics 18 June 2015

2 Disclosure Research funding received Medical Research Council (MRC) South Africa University of Kwazulu-Natal South African Society of Anaesthesiologists VISION (Vascular Events In Noncardiac Surgery) Troponin kits- Roche Diagnostics Over 50 grants internationally No other conflicts of interest 18 June 2015

3 Take home message Complex pathophysiology Little evidence to inform clinical guidelines 18 June 2015

4 Take home message Preoperative Coronary angiography does not identify the individual at risk Perioperative MI Difficult to determine the type of MI Postoperative Optimize medical therapy Stratify risk to determine appropriate coronary angiography 18 June 2015

5 Definition of Perioperative MI (PMI) Cardiac biomarker > 99th percentile upper ref limit and at least one of the following: Symptoms of ischaemia New ST T changes or LBBB Pathological Q waves New loss of viable myocardium Intracoronary thrombus 18 June 2015 Thygesen et al. J Am Coll Cardiol 2012;60(16):

6 Peri-operative myocardial infarction (PMI) Type 2: Supply-demand Type 1: Plaque rupture Probability Coronary stenosis 50% 70% 100% 18 June 2015 Landesberg et al. J Cardiothorac Vasc Anesth 2003;17(1):90-100

7 Prevalence of coronary lesions in at risk surgical patients Author Type of study LMS >50% Surgically correctable >70% Hertzer, 1984 Vascular 4% 25% CARP, 2005 CTA VISION, 2015 Vascular considered at risk At risk of cardiovascular disease 4.7% 43.9% 1.3% 40.3% 18 June 2015

8 Coronary revascularisation Long-term MACE MACE major adverse cardiac events 18 June 2015 Biccard BM, Rodseth RN. Anaesthesia 2009;64(10):

9 Problem no 1. Pre-noncardiac surgery MACE NNH 20 MACE major adverse cardiac events 18 June 2015 Biccard BM, Rodseth RN. Anaesthesia 2009;64(10):

10 Problem no 2. Site of PMI Inducible myocardial ischaemia 56% evidence of infarction in other areas 18 June 2015 Poldermans et al. Am J Cardiol 2001;88(12):1413-4, A6.

11 Prediction of MACE from pre-op coronary lesions PPV NPV Coronary stenosis > 70% 12% 94% Coronary stenosis > 50% 10% 95% 18 June 2015 Sheth et al. BMJ 2015;350:h1907.

12 Coronary lesions to distinguish bet types of PMI Type 1 Rupture Type 2 Supply-demand LMS >50% 18% 19% 3 vessels >50% 47% 56% 2 vessels >50% 24% 22% 1 vessels >50% 18% 11% 0 vessels >50% 0% 6% 18 June 2015 Duvall et al. Catheter Cardiovasc Interv 2012;80(5):

13 18 June 2015 Garcia et al. Am J Cardiol 2008;102(7): Possible indications: 1. Left main stem stenosis

14 Possible indications: 2. Mod-sev inducible ischaemia 18 June 2015 Landesberg et al. Eur Heart J 2007;28(5):533-9.

15 Coronary lesions in PMI Type 2: Supply-demand Type 1: Plaque rupture Probability Coronary stenosis 50% 70% 100% 18 June 2015 Landesberg et al. J Cardiothorac Vasc Anesth 2003;17(1):90-100

16 PATHOPHYSIOLOGY OF PERIOPERATIVE MI 18 June 2015

17 Clinical presentation PMI Presents predominantly as a non-occlusive lesion Type of myocardial ischaemia ST depression 40x> ST elevation Postoperative troponin release Postoperative ischaemia > 10min 18 June 2015 Landesberg G et al. J Am Coll Cardiol 2004;44(3):

18 Clinical presentation PMI Inflammation Coagulation Stress state Hypoxia Thrombosis Myocardial ischaemia Peri-operative myocardial injury 18 June 2015 Devereaux et al. CMAJ 2005; 173:

19 Clinical presentation PMI 18 June 2015 Beattie WS, et al. Anesth Analg 2008; 106:

20 Clinical presentation PMI 18 June 2015 Devereaux et al. Ann Intern Med 2011;154(8):523-28

21 Intracoronary thrombus formation Flow separation 18 June 2015 Biccard and Rodseth. Anaes 2010; 65:

22 Intracoronary thrombus formation Thrombus Recirculation and stasis zone 18 June 2015 Biccard and Rodseth. Anaes 2010; 65:

23 Predictors of PMI 18 June 2015 Devereaux et al. N Engl J Med 2014;370(16):

24 Time of presentation Type 1 Rupture Type 2 Supply-demand Later, spontaneous presentation Earlier presentation 18 June 2015 Biccard and Rodseth. Anaes 2010; 65:

25 Troponin release Type 1 and 2 PMI Type 2 PMI 18 June 2015 Le Manach et al. Anesthesiology 2005; 102:

26 Summary of PMI Characteristic Type 1 Rupture Coronary stenoses >50% >95% of all PMI Type 2 Supply-demand Incidence 44-55% 45-56% Multivessel coronary stenoses 92% 86% Presence intraluminal thrombus 52-66% 0-7% Postoperative day of presentation Pathophysiology Complex perioperative physiology 18 June 2015 Biccard BM, Rodseth RN. Anaesthesia 2010;65(7):

27 Summary of PMI Coronary stenoses are common High likelihood of intraluminal thrombus without total occlusion Majority can t distinguish on clinical presentation 18 June 2015 Biccard and Rodseth. Anaes 2010; 65:

28 MANAGEMENT OF PERIOPERATIVE MYOCARDIAL INFARCTION 18 June 2015

29 Possible management following PMI Oxygen, Optimize haemoglobin Aspirin +/- clopidogrel Statin, ACE-inhibitor Anticoagulation +/- morphine, +/- nitroglycerine Haemodynamically stable Haemodynamically unstable Beta-blockade Manage hypotension and dysrhythmias Add beta-blocker when stable Consider coronary angiogram if; 1. ST elevation 2. ST depression with recurrent symptoms and no contra-indication to heparin 18 June 2015 Biccard. Curr Opin Anaesthesiol 2014;27(3):

30 Possible management following PMI Drug therapy intensification No PMI No drug therapy intensification 18 June 2015 Fourcier et al. Anesth Analg 2014;119(5):

31 POST PMI CORONARY ANATOMY 18 June 2015

32 Indications for coronary angiography Indication Appropriate Potential perioperative Use equivalent Suspected CAD: No prior imaging Symptomatic with a Score (1 9) A (7) PMI following high pretest probability vascular surgery (>90% CAD) CTA VISION pretest probability for CAD following PMI is 92% 18 June 2015 Patel MR et al. J Am Coll Cardiol 2012;59:

33 Prevalence of surgically correctable coronary disease Lesion Procedure Class of evidence Preoperative Post PMI Unprotected LMS CABG/ PCI I/ IIa 4% (Hertzer) 15% (Duvall) 3 vessel CABG I 11% (Hertzer) 2 vessel with proximal LAD CABG I 9.4% (CTA VISION) 27% (CTA VISION) 18 June 2015 Jneid et al. Circulation 2012;126(7):

34 Early Delayed Contra-indicated TIMING OF CORONARY CATHETERIZATION 18 June 2015

35 Indications for immediate/ early coronary angiography STEMI Cardiogenic shock due to suspected ACS 18 June 2015 Patel et al. J Am Coll Cardiol 2012;59(22):

36 Evidence for early interventional strategy Presentation Medical therapy Invasive coronary intervention Haemodynamically stable 10 3 Haemodynamically unstable P-value June 2015 Ryan et al. SAJAA 2012;18(2):86-93.

37 Mortality associated with early interventional strategy Mortality Medical therapy Invasive coronary intervention P-value Haemodynamically unstable 40% 29.8% June 2015 Ryan et al. SAJAA 2012;18(2):86-93.

38 Early invasive strategy following NSTEMI Indication Class Refractory angina or haemodynamic or electrical instability I Stabilized, no serious comorbidities and risk of clinical events I Initially stabilized high-risk patients IIa 18 June 2015 Jneid et al. Circulation 2012;126(7):

39 Predictors of 30 day mortality following MINS Risk factor Adjusted OR (95% CI) Age 75 years old (1 point) 2.06 ( ) ST elevation or new LBBB (2 points) 3.96 ( ) Anterior ischaemic ECG findings (1 point) 2.33 ( ) 18 June 2015 Botto et al. Anesthesiology 2014;120(3):

40 30-day mortality, % Predictors of 30 day mortality following MINS % Total points Model Observed 18 June 2015 Botto et al. Anesthesiology 2014;120(3):

41 Early invasive strategy following NSTEMI: No benefit Indication Class Extensive comorbidities e.g. liver, pulmonary failure, cancer III With a low likelihood of ACS III 18 June 2015 Jneid et al. Circulation 2012;126(7):

42 Balance of risks and benefits Revascularization Medical therapy 18 June 2015

43 Risk: Bleeding 18 June 2015 Devereaux et al. N Engl J Med 2014;370(16):

44 Conservative management following NSTEMI Class I recommendation if an initial conservative strategy is selected and no subsequent features appear that would necessitate diagnostic angiography then a stress test should be performed 18 June 2015 Jneid et al. Circulation 2012;126(7):

45 Conclusions Preoperative Coronary angiography does not identify the individual at risk Perioperative MI Difficult to determine the type of MI Postoperative Optimize medical therapy Stratify risk to determine appropriate coronary angiography 18 June 2015

Perioperative Infarcts: Epidemiology, predictors and post-op monitoring

Perioperative Infarcts: Epidemiology, predictors and post-op monitoring Friday Nov 3rd, 2017 1pm Perioperative Infarcts: Epidemiology, predictors and post-op monitoring Dr Carol Chong Geriatrician Northern Health, Epping, Victoria, Australia How I became interested in this

More information

Acute Coronary Syndrome. Sonny Achtchi, DO

Acute Coronary Syndrome. Sonny Achtchi, DO Acute Coronary Syndrome Sonny Achtchi, DO Objectives Understand evidence based and practice based treatments for stabilization and initial management of ACS Become familiar with ACS risk stratification

More information

PERIOPERATIVE EVALUATION AND ANESTHETIC MANAGEMENT OF PATIENTS WITH CARDIAC DISEASE FOR NON CARDIAC SURGERY

PERIOPERATIVE EVALUATION AND ANESTHETIC MANAGEMENT OF PATIENTS WITH CARDIAC DISEASE FOR NON CARDIAC SURGERY PERIOPERATIVE EVALUATION AND ANESTHETIC MANAGEMENT OF PATIENTS WITH CARDIAC DISEASE FOR NON CARDIAC SURGERY WHICH PATIENT IS AT HIGHEST RISK? 1. 70 yo asymptomatic patient with history of heart failure

More information

Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology

Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology Cardiac evaluation for the noncardiac patient Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology Objectives! Review ACC / AHA guidelines as updated for 2009! Discuss new recommendations

More information

Post Operative Troponin Leak: David Smyth Christchurch New Zealand

Post Operative Troponin Leak: David Smyth Christchurch New Zealand Post Operative Troponin Leak: Does It Really Matter? David Smyth Christchurch New Zealand Life Was Simple Once Transmural Infarction Subendocardial Infarction But the Blood Tests Were n t Perfect Creatine

More information

What do the guidelines say?

What do the guidelines say? Percutaneous coronary intervention in 3-vessel disease and main stem What do the guidelines say? Nothing to disclose Dariusz Dudek Institute of Cardiology, Jagiellonian University Krakow, Poland The European

More information

Non ST Elevation-ACS. Michael W. Cammarata, MD

Non ST Elevation-ACS. Michael W. Cammarata, MD Non ST Elevation-ACS Michael W. Cammarata, MD Case Presentation 65 year old man PMH: CAD s/p stent in 2008 HTN HLD Presents with chest pressure, substernally and radiating to the left arm and jaw, similar

More information

Acute Coronary Syndromes

Acute Coronary Syndromes Overview Acute Coronary Syndromes Rabeea Aboufakher, MD, FACC, FSCAI Section Chief of Cardiology Altru Health System Grand Forks, ND Epidemiology Pathophysiology Clinical features and diagnosis STEMI management

More information

Chest Pain. Dr Robert Huggett Consultant Cardiologist

Chest Pain. Dr Robert Huggett Consultant Cardiologist Chest Pain Dr Robert Huggett Consultant Cardiologist Outline Diagnosis of cardiac chest pain 2016 NICE update on stable chest pain Assessment of unstable chest pain/acs and MI definition Scope of the

More information

Guidelines PATHOLOGY: FATAL PERIOPERATIVE MI NON-PMI N = 25 PMI N = 42. Prominent Dutch Cardiovascular Researcher Fired for Scientific Misconduct

Guidelines PATHOLOGY: FATAL PERIOPERATIVE MI NON-PMI N = 25 PMI N = 42. Prominent Dutch Cardiovascular Researcher Fired for Scientific Misconduct PATHOLOGY: FATAL PERIOPERATIVE MI NON-PMI N = 25 PMI N = 42 Preoperative, Intraoperative, and Postoperative Factors Associated with Perioperative Cardiac Complications in Patients Undergoing Major Noncardiac

More information

What is a myocardial infarction and how do we treat it? Paul Das Consultant Cardiologist North Wales Cardiac Centre Glan Clwyd Hospital

What is a myocardial infarction and how do we treat it? Paul Das Consultant Cardiologist North Wales Cardiac Centre Glan Clwyd Hospital What is a myocardial infarction and how do we treat it? Paul Das Consultant Cardiologist North Wales Cardiac Centre Glan Clwyd Hospital What is a myocardial infarction? THEY AINT WHAT THEY USED TO BE Case

More information

SESSION 5 2:20 3:35 pm

SESSION 5 2:20 3:35 pm SESSION 2:2 3:3 pm Strategies to Reduce Cardiac Risk for Noncardiac Surgery SPEAKER Lee A. Fleisher, MD Presenter Disclosure Information The following relationships exist related to this presentation:

More information

An update on the management of UA / NSTEMI. Michael H. Crawford, MD

An update on the management of UA / NSTEMI. Michael H. Crawford, MD An update on the management of UA / NSTEMI Michael H. Crawford, MD New ACC/AHA Guidelines 2007 What s s new in the last 5 years CT imaging advances Ascendancy of troponin and BNP Clarification of ACEI/ARB

More information

Patient referral for elective coronary angiography: challenging the current strategy

Patient referral for elective coronary angiography: challenging the current strategy Patient referral for elective coronary angiography: challenging the current strategy M. Santos, A. Ferreira, A. P. Sousa, J. Brito, R. Calé, L. Raposo, P. Gonçalves, R. Teles, M. Almeida, M. Mendes Cardiology

More information

Acute Coronary Syndrome. Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine

Acute Coronary Syndrome. Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine Acute Coronary Syndrome Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine Topics Timing is everything So many drugs to choose from What s a MINOCA? 2 Acute

More information

Perioperative Myocardial Infarction

Perioperative Myocardial Infarction Perioperative Myocardial Infarction Which patient should UNDERGO CORONARY ANGIOGRAPHY? The Cardiologists view Hans Rickli, St.Gallen 1 Experience Standards Risk stratification Team approach.. Tightrope

More information

Coronary Artery Disease: Revascularization (Teacher s Guide)

Coronary Artery Disease: Revascularization (Teacher s Guide) Stephanie Chan, M.D. Updated 3/15/13 2008-2013, SCVMC (40 minutes) I. Objectives Coronary Artery Disease: Revascularization (Teacher s Guide) To review the evidence on whether percutaneous coronary intervention

More information

Case Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA

Case Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA Case Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA Case History A 50-year-old man with type 1 diabetes mellitus and hypertension presents after experiencing 1 hour of midsternal chest pain that began after

More information

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such

More information

Chest pain and troponins on the acute take. J N Townend Queen Elizabeth Hospital Birmingham

Chest pain and troponins on the acute take. J N Townend Queen Elizabeth Hospital Birmingham Chest pain and troponins on the acute take J N Townend Queen Elizabeth Hospital Birmingham 3 rd Universal Definition of Myocardial Infarction Type 1: Spontaneous MI related to atherosclerotic plaque rupture

More information

Emergency surgery in acute coronary syndrome

Emergency surgery in acute coronary syndrome Emergency surgery in acute coronary syndrome Teerawoot Jantarawan Division of Cardiothoracic Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

More information

Belinda Green, Cardiologist, SDHB, 2016

Belinda Green, Cardiologist, SDHB, 2016 Acute Coronary syndromes All STEMI ALL Non STEMI Unstable angina Belinda Green, Cardiologist, SDHB, 2016 Thrombus in proximal LAD Underlying pathophysiology Be very afraid for your patient Wellens

More information

Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome

Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome Hiroyuki Okura*, MD; Nobuya Matsushita**,MD Kenji Shimeno**, MD; Hiroyuki Yamaghishi**, MD Iku Toda**,

More information

STEMI AND MULTIVESSEL CORONARY DISEASE

STEMI AND MULTIVESSEL CORONARY DISEASE STEMI AND MULTIVESSEL CORONARY DISEASE ΤΣΙΑΦΟΥΤΗΣ Ν. ΙΩΑΝΝΗΣ ΕΠΕΜΒΑΤΙΚΟΣ ΚΑΡΔΙΟΛΟΓΟΣ Α ΚΑΡΔΙΟΛΟΓΙΚΗ ΝΟΣ ΕΡΥΘΡΟΥ ΣΤΑΥΡΟΥ IRA 30-50% of STEMI patients have additional stenoses other than the infarct related

More information

Clinical Seminar. Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective

Clinical Seminar. Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective Clinical Seminar Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical

More information

ECG in coronary artery disease. By Sura Boonrat Central Chest Institute

ECG in coronary artery disease. By Sura Boonrat Central Chest Institute ECG in coronary artery disease By Sura Boonrat Central Chest Institute EKG P wave = Atrium activation PR interval QRS = Ventricle activation T wave= repolarization J-point EKG QT interval Abnormal repolarization

More information

The Universal Definition of Myocardial Infarction 3 rd revision, 2012

The Universal Definition of Myocardial Infarction 3 rd revision, 2012 The Universal Definition of Myocardial Infarction 3 rd revision, 2012 Joseph S. Alpert, MD Professor of Medicine, University of Arizona College of Medicine, Tucson, AZ; Editor-in-Chief, American Journal

More information

Coding an Acute Myocardial Infarction: Unravelling the Mystery

Coding an Acute Myocardial Infarction: Unravelling the Mystery Coding an Acute Myocardial Infarction: Unravelling the Mystery by Karen Carr, MS, BSN, RN, CCDS, CDIP, and Lisa Romanello, MSHI, BSN, RN, CCDS, CDIP WHITE PAPER Summary: The following white paper offers

More information

Essam Mahfouz, MD. Professor of Cardiology, Mansoura University

Essam Mahfouz, MD. Professor of Cardiology, Mansoura University By Essam Mahfouz, MD. Professor of Cardiology, Mansoura University Agenda Definitions Classifications Epidemiology Risk stratification What is new? What is MI? Myocardial infarction is the death of part

More information

ST SEGMENT THE UPS AND THE DOWNS

ST SEGMENT THE UPS AND THE DOWNS 07 October 2016 No. 23 ST SEGMENT THE UPS AND THE DOWNS M Nontshe Moderator: S Ramcharan School of Clinical Medicine Discipline of Anaesthesiology and Critical Care CONTENTS ST SEGMENT, THE UPS AND DOWNS...

More information

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Mun K. Hong, MD Associate Professor of Medicine Director, Cardiovascular Intervention and Research Weill Cornell

More information

Perioperative Management After Coronary Stenting: Risk Assessment Before Surgery. Christian Seiler No conflict of interest to declare.

Perioperative Management After Coronary Stenting: Risk Assessment Before Surgery. Christian Seiler No conflict of interest to declare. Perioperative Management After Coronary Stenting: Risk Assessment Before Surgery Christian Seiler No conflict of interest to declare PCI Long-Term Outcome Perioperative Management After Coronary Stenting:

More information

UPDATE ON THE MANAGEMENTACUTE CORONARY SYNDROME. DR JULES KABAHIZI, Psc (Rwa) Lt Col CHIEF CONSULTANT RMH/KFH 28 JUNE18

UPDATE ON THE MANAGEMENTACUTE CORONARY SYNDROME. DR JULES KABAHIZI, Psc (Rwa) Lt Col CHIEF CONSULTANT RMH/KFH 28 JUNE18 UPDATE ON THE MANAGEMENTACUTE CORONARY SYNDROME DR JULES KABAHIZI, Psc (Rwa) Lt Col CHIEF CONSULTANT RMH/KFH 28 JUNE18 INTRODUCTION The clinical entities that comprise acute coronary syndromes (ACS)-ST-segment

More information

Perioperative Cardiology Consultations for Noncardiac Surgery Ischemic Heart Disease

Perioperative Cardiology Consultations for Noncardiac Surgery Ischemic Heart Disease 2012 대한춘계심장학회 Perioperative Cardiology Consultations for Noncardiac Surgery Ischemic Heart Disease 울산의대울산대학병원심장내과이상곤 ECG CLASS IIb 1. Preoperative resting 12-lead ECG may be reasonable in patients with

More information

Post-Procedural Myocardial Injury or Infarction

Post-Procedural Myocardial Injury or Infarction Post-Procedural Myocardial Injury or Infarction Hugo A Katus MD & Evangelos Giannitsis MD Abteilung Innere Medizin III Kardiologie, Angiologie, Pulmologie Universitätsklinikum Heidelberg Conflict of Interest:

More information

NSTE ACS. Timing of intervention

NSTE ACS. Timing of intervention NSTE ACS Timing of intervention Timing of intervention in NSTE-ACS What do the guidelines tell us? Any need for immediate invasive approach? No mortality benefit with an early invasive approach? Putting

More information

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME

More information

The NICE chest pain guideline 1 year on. Jane S Skinner Consultant Community Cardiologist The Newcastle upon Tyne Hospitals NHS Foundation Trust

The NICE chest pain guideline 1 year on. Jane S Skinner Consultant Community Cardiologist The Newcastle upon Tyne Hospitals NHS Foundation Trust The NICE chest pain guideline 1 year on Jane S Skinner Consultant Community Cardiologist The Newcastle upon Tyne Hospitals NHS Foundation Trust The Society for Acute Medicine, 5 th International Conference,

More information

Peri-operative Troponin Measurements - Pathophysiology and Prognosis

Peri-operative Troponin Measurements - Pathophysiology and Prognosis Peri-operative Troponin Measurements - Pathophysiology and Prognosis Allan S. Jaffe, MD.* Consultant - Cardiology & Laboratory Medicine Professor of Medicine Chair, CCLS Division, Department of Laboratory

More information

Acute coronary syndromes

Acute coronary syndromes Acute coronary syndromes 1 Acute coronary syndromes Acute coronary syndromes results primarily from diminished myocardial blood flow secondary to an occlusive or partially occlusive coronary artery thrombus.

More information

South Afr J Anaesth Analg RESEARCH

South Afr J Anaesth Analg RESEARCH Southern African Journal of Anaesthesia and Analgesia 2017; 23(3):64 68 https://doi.org/10.1080/22201181.2017.1317992 Open Access article distributed under the terms of the Creative Commons License [CC

More information

Perioperative Medical Therapy: Beta Blockers, Statins, ACE-Inhibitors, ARB Effects on Mortality

Perioperative Medical Therapy: Beta Blockers, Statins, ACE-Inhibitors, ARB Effects on Mortality Perioperative Medical Therapy: Beta Blockers, Statins, ACE-Inhibitors, ARB Effects on Mortality Art Wallace, MD, PhD SF VAMC Chief of Anethesia and Vice Chair of Anesthesia and Perioperative Care UCSF

More information

Revascularization in Severe LV Dysfunction: The Role of Inducible Ischemia and Viability Testing

Revascularization in Severe LV Dysfunction: The Role of Inducible Ischemia and Viability Testing Revascularization in Severe LV Dysfunction: The Role of Inducible Ischemia and Viability Testing Evidence and Uncertainties Robert O. Bonow, MD, MS, MACC Northwestern University Feinberg School of Medicine

More information

Acute Coronary Syndromes. January 9, 2013 Chris Chiles M.D. FACC

Acute Coronary Syndromes. January 9, 2013 Chris Chiles M.D. FACC Acute Coronary Syndromes January 9, 2013 Chris Chiles M.D. FACC Disclosures None- not even a breakfast burrito from a drug company Hospitalizations in the U.S. Due to ACS Acute Coronary Syndromes* 1.57

More information

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD Hein J. Verberne Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands International Conference

More information

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor 76 year old female Prior Hypertension, Hyperlipidemia, Smoking On Hydrochlorothiazide, Atorvastatin New onset chest discomfort; 2 episodes in past 24 hours Heart rate 122/min; BP 170/92 mm Hg, Killip Class

More information

Acute Myocardial Infarction. Willis E. Godin D.O., FACC

Acute Myocardial Infarction. Willis E. Godin D.O., FACC Acute Myocardial Infarction Willis E. Godin D.O., FACC Acute Myocardial Infarction Definition: Decreased delivery of oxygen and nutrients to the myocardium Myocardial tissue necrosis causing irreparable

More information

Preoperative Cardiac Risk Assessment: Approach & Guidelines

Preoperative Cardiac Risk Assessment: Approach & Guidelines Preoperative Cardiac Risk Assessment: Approach & Guidelines By, Liam Morris, MD., FACC (02/03/18) CPG : Clinical Practice Guidelines GDMT : Guidelines Directed Medical Therapy GWC : Guideline Writing Committee

More information

8/28/2018. Pre-op Evaluation for non cardiac surgery. A quick review from 2007!! Disclosures. John Steuter, MD. None

8/28/2018. Pre-op Evaluation for non cardiac surgery. A quick review from 2007!! Disclosures. John Steuter, MD. None Pre-op Evaluation for non cardiac surgery John Steuter, MD Disclosures None A quick review from 2007!! Fliesheret al, ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and are for Noncardiac

More information

Fractional Flow Reserve: Basics, FAME 1, FAME 2. William F. Fearon, MD Associate Professor Stanford University Medical Center

Fractional Flow Reserve: Basics, FAME 1, FAME 2. William F. Fearon, MD Associate Professor Stanford University Medical Center Fractional Flow Reserve: Basics, FAME 1, FAME 2 William F. Fearon, MD Associate Professor Stanford University Medical Center Conflict of Interest Advisory Board for HeartFlow Research grant from St. Jude

More information

Timing of Surgery After Percutaneous Coronary Intervention

Timing of Surgery After Percutaneous Coronary Intervention Timing of Surgery After Percutaneous Coronary Intervention Deepak Talreja, MD, FACC Bayview/EVMS/Sentara Outline/Highlights Timing of elective surgery What to do with medications Stopping anti-platelet

More information

Chest pain management. Ruvin Gabriel and Niels van Pelt August 2011

Chest pain management. Ruvin Gabriel and Niels van Pelt August 2011 Chest pain management Ruvin Gabriel and Niels van Pelt August 2011 Introduction Initial assessment Case 1 Case 2 and 3 Comparison of various diagnostic techniques Summary 1-2 % of GP consultations are

More information

2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non ST-Elevation Myocardial Infarction

2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non ST-Elevation Myocardial Infarction 2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non ST-Elevation Myocardial Infarction Ramzi Khalil MD FACC Assistant Professor Allegheny Gen.Hospital AHN Speakers

More information

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions Julinda Mehilli, MD Deutsches Herzzentrum Technische Universität Munich Germany ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions Background Left main

More information

Benefit of Performing PCI Based on FFR

Benefit of Performing PCI Based on FFR Benefit of Performing PCI Based on FFR William F. Fearon, MD Associate Professor Director, Interventional Cardiology Stanford University Medical Center Benefit of FFR-Guided PCI FFR-Guided PCI vs. Angiography-Guided

More information

How will new high sensitive troponins affect the criteria?

How will new high sensitive troponins affect the criteria? How will new high sensitive troponins affect the criteria? Hugo A Katus MD Abteilung Innere Medizin III Kardiologie, Angiologie, Pulmologie Universitätsklinikum Heidelberg Even more sensitive: The new

More information

ST Elevation Myocardial Infarction

ST Elevation Myocardial Infarction ST Elevation Myocardial Infarction Scott M. Lilly, MD, PhD Assistant Professor Clinical Department of Cardiovascular Medicine The Ohio State University Wexner Medical Center Case Presentation 46 year old

More information

10/22/16. Lay of the land. Definition of ACS. Why do we worry about ST elevations?

10/22/16. Lay of the land. Definition of ACS. Why do we worry about ST elevations? Lay of the land Update on Acute Coronary Syndrome: Five Things Hospitalists Must Know Dhruv S. Kazi, MD, MSc, MS Assistant Professor Department of Medicine (Cardiology), Department of Epidemiology and

More information

PERIOPERATIVE CARDIAC RISK ASSESSMENT. Divya Gollapudi, MD

PERIOPERATIVE CARDIAC RISK ASSESSMENT. Divya Gollapudi, MD PERIOPERATIVE CARDIAC RISK ASSESSMENT Divya Gollapudi, MD Clinical Assistant Professor Hospital Medicine Program Division of General Internal Medicine Harborview Medical Center None Disclosures Objectives

More information

Cindy L. Grines MD FACC FSCAI

Cindy L. Grines MD FACC FSCAI Cindy L. Grines MD FACC FSCAI Hofstra Northwell School of Medicine Chair, Cardiology Academic Chief of Cardiology, Northwell Health North Shore University Hospital, Manhasset NY Multivessel Disease in

More information

Quinn Capers, IV, MD

Quinn Capers, IV, MD Heart Attacks Mended Hearts Presentation, January, 2017 Quinn Capers, IV, MD Associate Professor of Medicine (Cardiovascular Medicine) Director, Transradial Coronary Interventions Division of Cardiovascular

More information

Target vessel only revascularization versus complet revascularization in non culprit lesions in acute myocardial infarction treated by primary PCI

Target vessel only revascularization versus complet revascularization in non culprit lesions in acute myocardial infarction treated by primary PCI Target vessel only revascularization versus complet revascularization in non culprit lesions in acute myocardial infarction treated by primary PCI Gamal Abdelhady, Emad Mahmoud Department of interventional

More information

2010 ACLS Guidelines. Primary goals of therapy for patients

2010 ACLS Guidelines. Primary goals of therapy for patients 2010 ACLS Guidelines Part 10: Acute Coronary Syndrome Present : 內科 R1 鍾伯欣 Supervisor: F1 吳亮廷 991110 Primary goals of therapy for patients of ACS Reduce the amount of myocardial necrosis that occurs in

More information

Approach to Multi Vessel disease with STEMI

Approach to Multi Vessel disease with STEMI Approach to Multi Vessel disease with STEMI MANAGEMENT OF ST-ELEVATION MYOCARDIAL INFARCTION Dr. Thomas Alexander, M.D; D.M; F.A.C.C. Senior Consultant and Interventional Cardiologist Kovai Medical Centre

More information

DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN

DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN Objectives Gain competence in evaluating chest pain Recognize features of moderate risk unstable angina Review initial management of UA and

More information

Early cardiology assessment and intervention reduces mortality following myocardial injury after non-cardiac surgery (MINS)

Early cardiology assessment and intervention reduces mortality following myocardial injury after non-cardiac surgery (MINS) Original Article Early cardiology assessment and intervention reduces mortality following myocardial injury after non-cardiac surgery (MINS) Alina Hua 1, Holly Pattenden 1, Maria Leung 1, Simon Davies

More information

New universal definition of myocardial infarction

New universal definition of myocardial infarction New universal definition of myocardial infarction L. K. Michalis, ΜRCP, FESC Professor of Cardiology, University of Ioannina Changing Criteria for definition of MI Primarily clinical & ECG approach First

More information

Measuring Natriuretic Peptides in Acute Coronary Syndromes

Measuring Natriuretic Peptides in Acute Coronary Syndromes Measuring Natriuretic Peptides in Acute Coronary Syndromes Peter A. McCullough, MD, MPH, FACC, FACP, FAHA, FCCP Consultant Cardiologist Chief Academic and Scientific Officer St. John Providence Health

More information

Acute Coronary Syndrome

Acute Coronary Syndrome Acute Coronary Syndrome Clinical Manifestation of CAD Silent Ischemia/asymptomatic Stable Angina Acute Coronary Syndrome (Non- STEMI/UA and STEMI) Arrhythmias Heart Failure Sudden Death Pain patterns with

More information

Preoperative Evaluation Guidelines and Work up

Preoperative Evaluation Guidelines and Work up Preoperative Evaluation Guidelines and Work up Wesley Fiser, MD Disclosures: None 1 Case An 80 year old woman with osteoarthritis of the hip, DM, CKD (Cr 2.1), and HTN is diagnosed with an obstructing

More information

ST Elevation Myocardial Infarction

ST Elevation Myocardial Infarction ST Elevation Myocardial Infarction Scott M. Lilly, MD, PhD Assistant Professor Clinical Department of Cardiovascular Medicine The Ohio State University Wexner Medical Center Outline Case Presentation STEMI

More information

Treatment Options for Angina

Treatment Options for Angina Treatment Options for Angina Interventional Cardiology Perspective Michael A. Robertson, M.D. 10/30/10 Prevalence of CAD in USA 15 million Americans with CAD 2 million diagnostic catheterizations 1 million

More information

CLINICIAN INTERVIEW RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE. An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA

CLINICIAN INTERVIEW RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE. An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA Dr Lincoff is an interventional cardiologist and the Vice Chairman for Research

More information

Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI

Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist physician Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI Outcome objectives of the discussion: At the end of the

More information

REVISED MI DEFINITIONS IMPLICATIONS FOR CLINICAL TRIALS. Maarten L Simoons Thoraxcenter - Erasmus MC Rotterdam - The Netherlands

REVISED MI DEFINITIONS IMPLICATIONS FOR CLINICAL TRIALS. Maarten L Simoons Thoraxcenter - Erasmus MC Rotterdam - The Netherlands REVISED MI DEFINITIONS IMPLICATIONS FOR CLINICAL TRIALS Maarten L Simoons Thoraxcenter - Erasmus MC Rotterdam - The Netherlands TRITON Prasugrel ACS + PCI n = 13,608 moderate / high risk ACS, all PCI p

More information

Diagnostics consultation document

Diagnostics consultation document National Institute for Health and Care Excellence Diagnostics consultation document Myocardial infarction (acute): Early rule out using high-sensitivity troponin tests (Elecsys Troponin T high-sensitive,

More information

Medicine Dr. Omed Lecture 2 Stable and Unstable Angina

Medicine Dr. Omed Lecture 2 Stable and Unstable Angina Medicine Dr. Omed Lecture 2 Stable and Unstable Angina Risk stratification in stable angina. High Risk; *post infarct angina, *poor effort tolerance, *ischemia at low workload, *left main or three vessel

More information

Recognizing the High Risk NSTEMI Patient for Early Appropriate Therapy

Recognizing the High Risk NSTEMI Patient for Early Appropriate Therapy Recognizing the High Risk NSTEMI Patient for Early Appropriate Therapy Learning Objectives Learn to recognize the high risk patient Discuss effective management of a high risk NSTEMI patient Review CCS

More information

GUIDELINE 14 ACUTE CORONARY SYNDROMES

GUIDELINE 14 ACUTE CORONARY SYNDROMES AUSTRALIAN RESUSCITATION COUNCIL GUIDELINE 14 ACUTE CORONARY SYNDROMES OVERVIEW AND SUMMARY As a part of the International Liaison Committee on Resuscitation (ILCOR) process that led to the International

More information

UPDATES FROM THE 2018 ANTIPLATELET GUIDELINES

UPDATES FROM THE 2018 ANTIPLATELET GUIDELINES UPDATES FROM THE 2018 ANTIPLATELET GUIDELINES Claudia Bucci BScPhm, PharmD Clinical Coordinator, Cardiovascular Diseases Sunnybrook Health Sciences Centre 21st Annual Contemporary Therapeutic Issues in

More information

FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium

FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium Conflict of Interest Institutional research grants and speaker s fee from St. Jude Medical and Boston Scientic to Cardiovascular

More information

Cardiogenic Shock. Carlos Cafri,, MD

Cardiogenic Shock. Carlos Cafri,, MD Cardiogenic Shock Carlos Cafri,, MD SHOCK= Inadequate Tissue Mechanisms: Perfusion Inadequate oxygen delivery Release of inflammatory mediators Further microvascular changes, compromised blood flow and

More information

Rationale for Prophylactic Support During Percutaneous Coronary Intervention

Rationale for Prophylactic Support During Percutaneous Coronary Intervention Rationale for Prophylactic Support During Percutaneous Coronary Intervention Navin K. Kapur, MD, FACC, FSCAI Assistant Director, Interventional Cardiology Director, Interventional Research Laboratories

More information

2010, Metzler Helfried

2010, Metzler Helfried Perioperative Strategies in Patients on Dual Antiplatelet Drug Therapy: Noncardiac Surgery H. Metzler Department of Anaesthesiology and Intensive Care Medicine Medical University of Graz, Austria What

More information

Low Dose Rivaroxaban Versus Aspirin, in Addition to P2Y12 Inhibition, in Acute Coronary Syndromes (GEMINI-ACS-1)

Low Dose Rivaroxaban Versus Aspirin, in Addition to P2Y12 Inhibition, in Acute Coronary Syndromes (GEMINI-ACS-1) Low Dose Rivaroxaban Versus Aspirin, in Addition to P2Y12 Inhibition, in Acute Coronary Syndromes (GEMINI-ACS-1) Caitlin C. Akerman, PharmD PGY2 Cardiology Resident WakeMed Health & Hospitals Raleigh,

More information

Clopidogrel and ASA after CABG for NSTEMI

Clopidogrel and ASA after CABG for NSTEMI Clopidogrel and ASA after CABG for NSTEMI May 17, 2007 Justin Lee Pharmacy Resident University Health Network Objectives At the end of this session, you should be able to: Explain the rationale for antiplatelet

More information

Acute Coronary Syndrome. Emergency Department Updated Jan. 2017

Acute Coronary Syndrome. Emergency Department Updated Jan. 2017 Acute Coronary Syndrome Emergency Department Updated Jan. 2017 Goals and Objectives To reduce mortality and morbidity for people who have cardiovascular disease, with a focus on those who experience an

More information

Appendix: ACC/AHA and ESC practice guidelines

Appendix: ACC/AHA and ESC practice guidelines Appendix: ACC/AHA and ESC practice guidelines Definitions for guideline recommendations and level of evidence Recommendation Class I Class IIa Class IIb Class III Level of evidence Level A Level B Level

More information

Clinical Controversies in Perioperative Medicine

Clinical Controversies in Perioperative Medicine Clinical Controversies in Perioperative Medicine Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Cardiac Evaluation: New Guidelines A 70-y.o. man with progressive

More information

Out-of-hospital Cardiac Arrest. Franz R. Eberli MD, FESC, FAHA Cardiology Triemli Hospital Zurich, Switzerland

Out-of-hospital Cardiac Arrest. Franz R. Eberli MD, FESC, FAHA Cardiology Triemli Hospital Zurich, Switzerland Out-of-hospital Cardiac Arrest Franz R. Eberli MD, FESC, FAHA Cardiology Triemli Hospital Zurich, Switzerland Conflict of Interest I have no conflict of interest to disclose regarding this presentation.

More information

Myocardial injury, necrosis and infarction

Myocardial injury, necrosis and infarction Myocardial injury, necrosis and infarction Harvey White Green Lane Cardiovascular Service and Cardiovascular Research Unit Auckland City Hospital, Auckland, New Zealand Faculty Disclosure In accordance

More information

How to approach non-infarct related artery disease in patients with STEMI in a limited resource setting

How to approach non-infarct related artery disease in patients with STEMI in a limited resource setting How to approach non-infarct related artery disease in patients with STEMI in a limited resource setting Ahmed A A Suliman, MBBS, FACP, FESC Associate Professor, University of Khartoum Interventional Cardiologist,

More information

PCI for Left Anterior Descending Artery Ostial Stenosis

PCI for Left Anterior Descending Artery Ostial Stenosis PCI for Left Anterior Descending Artery Ostial Stenosis Why do you hesitate PCI for LAD ostial stenosis? LAD Ostial Lesion Limitations of PCI High elastic recoil Involvement of the distal left main coronary

More information

PACT module High risk surgical patient. Intensive Care Training Program Radboud University Medical Centre Nijmegen

PACT module High risk surgical patient. Intensive Care Training Program Radboud University Medical Centre Nijmegen PACT module High risk surgical patient Intensive Care Training Program Radboud University Medical Centre Nijmegen Intravascular volume effect of Ringer s lactate Double-tracer BV measurement Blood 1097

More information

FastTest. You ve read the book now test yourself

FastTest. You ve read the book now test yourself FastTest You ve read the book...... now test yourself To ensure you have learned the key points that will improve your patient care, read the authors questions below. The answers will refer you back to

More information

Disclosures. Inpatient Management of Non-ST Elevation Acute Coronary Syndromes. Edward McNulty MD, FACC. None

Disclosures. Inpatient Management of Non-ST Elevation Acute Coronary Syndromes. Edward McNulty MD, FACC. None Inpatient Management of Non-ST Elevation Acute Coronary Syndromes Edward McNulty MD, FACC Assistant Clinical Professor UCSF Director, SF VAMC Cardiac Catheterization Laboratory Disclosures None New Guidelines

More information

Diagnostics guidance Published: 1 October 2014 nice.org.uk/guidance/dg15

Diagnostics guidance Published: 1 October 2014 nice.org.uk/guidance/dg15 Myocardial infarction (acute): Early rule out using high-sensitivity troponin tests (Elecsys Troponin T high-sensitive, e, ARCHITECT STAT T High Sensitive Troponin-I and AccuTnI+3 assays) Diagnostics guidance

More information

EAE Teaching Course. Magnetic Resonance Imaging. Competitive or Complementary? Sofia, Bulgaria, 5-7 April F.E. Rademakers

EAE Teaching Course. Magnetic Resonance Imaging. Competitive or Complementary? Sofia, Bulgaria, 5-7 April F.E. Rademakers EAE Teaching Course Magnetic Resonance Imaging Competitive or Complementary? Sofia, Bulgaria, 5-7 April 2012 F.E. Rademakers Complementary? Of Course N Engl J Med 2012;366:54-63 Clinical relevance Treatment

More information

Cardiovascular emergencies. 05/March/2014 László Rudas Szeged

Cardiovascular emergencies. 05/March/2014 László Rudas Szeged Cardiovascular emergencies 05/March/2014 László Rudas Szeged Acute chest pain Acute heart failure Sudden cardiac death Acute chest pain What is the etiology? Chest pain signals emergency: - ACS - Pulmonary

More information

Cangrelor: Is it the new CHAMPION for PCI? Robert Barcelona, PharmD, BCPS Clinical Pharmacy Specialist, Cardiac Intensive Care Unit November 13, 2015

Cangrelor: Is it the new CHAMPION for PCI? Robert Barcelona, PharmD, BCPS Clinical Pharmacy Specialist, Cardiac Intensive Care Unit November 13, 2015 Cangrelor: Is it the new CHAMPION for PCI? Robert Barcelona, PharmD, BCPS Clinical Pharmacy Specialist, Cardiac Intensive Care Unit November 13, 2015 Objectives Review the pharmacology and pharmacokinetic

More information